Harald Mothes

Peptisyntha SA manufactures and supplies small to commercial scale cGMP peptide APIs for pharmaceutical and biotech companies. The firm offers solid-phase peptide synthesis, liquid-phase peptide synthesis, hybrid strategies, complex peptides and peptidomimetics, peptide-conjugations, cyclic peptides and multiple disulfide bridges peptides, short peptides, and arginine-rich peptides. It serves customers worldwide. Peptisyntha was founded in 1987 and is headquartered in Brussels, Belgium.

Part of Solvay SA, Solvay Fluor GmbH is a German multi-specialty chemical company committed to developing chemistry that addresses key societal challenges. The company is based in Hannover, Germany. Solvay innovates and partners with customers in diverse end markets. The CEOs are Christoph Meurer, Johannes Eicher. The company was founded in 2000.

Solvin Europe GmbH provides management services. The private company is based in Hannover, Germany. The CEOs are Wolf Sanner, Alexandere Blum. The German company was founded in 1999.

Part of Nitto Denko Corp., Girindus America, Inc. provides oligonucleotide research and production services. The company is based in Cincinnati, OH. The CEO of the company is Marc M. Lemaître. Girindus America was acquired by Nitto Denko Avecia, Inc. from Girindus AG i.L. on January 30, 2013 for $12.60 million.

Pharmafluidics NV develops micro chip liquid chromatography cartridges for analysis of complex biological samples. The company was founded by Wim De Malsche, Joeri Denayer, Gert Desme and Paul Godelieve Jacobs in 2010 and is headquartered in Ghent, Belgium.

Part of Groupe Bruxelles Lambert SA, Imerys PCC France SASU is a French company that manufactures inorganic chemicals. The company is based in Arles, France.

Part of Solvac SA, Solvay Fluores France S.A.S. is a French company that manufactures and supplies fluorine chemicals. The company is based in Aubervilliers, France and was founded in 1997.

Part of Groupe Bruxelles Lambert SA, Imerys PCC UK Ltd. is a company that delivers high value-added, functional solutions to a great number of industries, ranging from process manufacturing to consumer goods. The company is based in Northwich, UK. These names are synonymous with quality and dependability, and are recognized and sought after internationally, forming the front line of the Imerys business. Imerys offers the TERNAL range of calcium aluminate binders developed to provide specific benefits to even the most demanding formulations. Founded in 1998, the British company's brands are established and respected around the world, serving a wide range of sectors and industries, products and applications.

Solvay Infra Bad Hönningen GmbH manufactures and distributes industrial chemicals. The company is based in Hannover, Germany.

Solvay Sisecam Holding AG operates as a holding company with interest in operating soda ash producing plants and factories. The company was founded in 1997 and is headquartered in Vienna, Austria.

Part of Solvay SA, Solvay Chemicals GmbH is a German multi-specialty chemical company that develops chemistry to address key societal challenges and partners with customers in diverse end markets. The company is based in Hannover, Germany. The CEOs are Hugo Walravens, Norber Mülders. The company was founded in 2000.

Part of Solvay SA, Solvay Specialty Polymers Germany GmbH is a multi-specialty chemical company that develops chemistry to address key societal challenges. The company is based in Hannover, Germany. The company partners with customers in diverse end markets. The CEOs are Wolf Sanner, Thomas Kohnert. The company was founded in 1999.

Part of Solvay SA, Salzgewinnungsgesellschaft Westfalen GmbH & Co. KG is a German company that engages in the extraction of salt. The company is based in Hannover, Germany.

Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators.